# Erytech Pharma - Spon ADR (PHXM)

> Institutional ownership reported to the SEC as of Q1 2024, from Form 13F filings. Source: https://holderbook.com/stocks/PHXM/

- Reporting holders: 1
- Reported value: $1.0K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Asset Dedication, LLC](https://holderbook.com/funds/1475896-asset-dedication-llc/) | $1.0K | 400 | 0.0% | 3 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q1 2024 | 1 | $1.0K |
| Q4 2023 | 1 | $2.0K |
| Q3 2023 | 3 | $3.6K |
| Q2 2023 | 9 | $99.3K |
| Q1 2023 | 9 | $374.9K |
| Q4 2022 | 8 | $244.9K |
| Q3 2022 | 9 | $784.0K |
| Q2 2022 | 7 | $1.7M |
| Q1 2022 | 6 | $6.7M |
| Q4 2021 | 9 | $11.2M |
| Q3 2021 | 10 | $11.6M |
| Q2 2021 | 4 | $9.4M |